Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2013). Letter to the editor: A potential mechanism for the pathogenesis of psoriasis vulgaris. International Journal of Dermatology, 52(11), 1429 - 1432.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2012). Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: A cross-sectional and longitudinal study. American Journal of Clinical Dermatology, 13(1), 37 - 47.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2012). Letter to the Editor: A potential mechanism for the pathogenesis of psoriasis vulgaris. International Journal of Dermatology.

Coimbra, S., Figueiredo, A., Castro, E., Rocha-Pereira, P., & Santos-Silva, A. (2012). The roles of cells and cytokines in the pathogenesis of psoriasis. International Journal of Dermatology, 51(4), 389 - 398.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2010). Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. Journal of the European Academy of Dermatology and Venereology, 24(12), 1386 - 1394.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2010). C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. Journal of the European Academy of Dermatology and Venereology, 24(7), 789 - 796.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2010). Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-? levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. British Journal of Dermatology, 163(6), 1282 - 1290.

Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2009). Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. Journal of Dermatological Science, 55(3), 202 - 204.

Costa, E., Rocha, S., Rocha-Pereira, P., Reis, F., et al. (2009). Effect of hemodialysis procedure in prohepcidin serum levels in regular hemodialysis patients. Clinical Nephrology, 71(2), 233 - 235.

Costa, E., Rocha, S., Rocha-Pereira, P., Castro, E., et al. (2008). Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under haemodialysis and recombinant human erythropoietin therapy. Blood Purification, 26(3), 267 - 273.

Costa, E., Rocha, S., Rocha-Pereira, P., Castro, E., et al. (2008). Changes in red blood cells membrane protein composition during hemodialysis procedure. Renal Failure, 30(10), 971 - 975.

Costa, E., Rocha, S., Rocha-Pereira, P., Castro, E., et al. (2008). Cross-talk between inflammation, coagulation/fibrinolysis and vascular access in hemodialysis patients. Journal of Vascular Access, 9(4), 248 - 253.

Costa, E., Rocha, S., Rocha-Pereira, P., Reis, F., et al. (2008). DMT1 (NRAMP2/DCT1) Genetic Variability and Resistance to Recombinant Human Erythropoietin Therapy in Chronic Kidney Disease Patients under Haemodialysis. Acta Haematologica, 120(1), 11 - 13.

Costa, E., Lima, M., Rocha, S., Rocha-Pereira, P., et al. (2008). IL-7 serum levels and lymphopenia in hemodialysis patients, non-responders to recombinant human erythropoietin therapy. Blood Cells, Molecules, and Diseases, 41(1), 134 - 135.

Costa, E., Lima, M., Alves, J. M., Rocha, S., et al. (2008). Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. Journal of Clinical Immunology, 28(3), 268 - 275.

Costa, E., Rocha, S., Rocha-Pereira, P., Nascimento, H., et al. (2008). Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. American Journal of Nephrology, 28(6), 935 - 940.

Costa, E., Pereira, B. J. G., Rocha-Pereira, P., Rocha, S., et al. (2008). Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. American Journal of Nephrology, 28(4), 677 - 683.

Coimbra, S., Castro, E., Rocha-Pereira, P., Rebelo, I., et al. (2006). The effect of green tea in oxidative stress. Clinical Nutrition, 25(5), 790 - 796.

Coimbra, S., Santos-Silva, A., Rocha-Pereira, P., Rocha, S., & Castro, E. (2006). Green tea consumption improves plasma lipid profiles in adults. Nutrition Research, 26(11), 604 - 607.